HCP Media Library

Watch and listen to learn more about colorectal cancer (CRC) screening.

Mission to Screen

Katie Couric and Dr. David Poppers discuss the Mission to Screen for colorectal cancer (CRC).

Poppers

David Poppers, MD, PhD, FACP, AGAF, FASGE

Dr. David Poppers is Clinical Professor of Medicine at the NYU Grossman School of Medicine and Director of GI Quality and Strategic Initiatives at the NYU Preston Robert Tisch Center for Men’s Health and Joan Tisch Center for Women’s Health at NYU Langone Health in New York. He served as founding director of the Interventional Endoscopy Fellowship Program at NYU Langone. He serves on the Quality Improvement Committee and the Institutional Review Board Committee among other roles at NYU. Dr. Poppers received his medical and research training at New York University School of Medicine (MD, PhD). He completed his internship in internal medicine and residency at the Massachusetts General Hospital in Boston, and his fellowship in gastroenterology and hepatology at New York Presbyterian-Weill Cornell Medical Center in New York, followed by additional specialized training in advanced/interventional endoscopy at Lenox Hill Hospital.


Dr. Durado Brooks Reviews the Current State of Colorectal Cancer (CRC) Screening

Watch Dr. Brooks discuss various topics pertaining to CRC and Cologuard®

Durado Brooks, MD, MPH, is the Deputy Chief Medical Officer at Exact Sciences.

In this role he serves as liaison for scientifically driven engagements, and contributes to the design, conduct, and reporting of innovative research. Dr. Brooks leads strategic outreach and collaboration, designed to increase cancer screening and improve outcomes in traditionally underserved populations. An internist by training, he has spent much of his career working to enhance the role of prevention in primary care, and to improve care for medically underserved populations. An Ohio native, Dr. Brooks received his medical degree from Wright State University School of Medicine in Dayton, Ohio, where he subsequently completed his internal medicine residency and served as Chief Resident. Additionally, Dr. Brooks holds a Master of Public Health (MPH) degree from the Harvard School of Public Health. Prior to joining Exact Sciences, Dr. Brooks was the Vice President of Prevention and Early Detection for the American Cancer Society. His work involved creating strategies to improve the prevention and early detection of cancer, and to assist those who are diagnosed with the disease.


  • The U.S. Preventive Services Task Force (USPSTF) recommends starting colorectal cancer (CRC) screening for average-risk patients at age 45 (Grade B recommendation) 1*

    Listen in to hear about the recent update to the USPSTF CRC screening recommendations for average risk patients, including starting screening at age 45. This video will also provide an overview of the evidence that supports the new screening age and the potential impact of offering choice in CRC screening.

    Dr. Paul Limburg, a gastroenterologist with over 20 years of experience in clinical practice and the Chief Medical Officer for Screening at Exact Sciences, shares insights on how this update may impact CRC screening in your practice.

     

    Listen in to hear about the recent update to the USPSTF CRC screening recommendations for average risk patients, including starting screening at age 45. This video will also provide an overview of the evidence that supports the new screening age and the potential impact of offering choice in CRC screening.

    Dr. Paul Limburg, a gastroenterologist with over 20 years of experience in clinical practice and the Chief Medical Officer for Screening at Exact Sciences, shares insights on how this update may impact CRC screening in your practice.

     

    Dr. Paul Limburg,
    Chief Medical Officer,
    Screening at Exact Sciences

    Dr. Limburg holds the academic rank of Professor of Medicine in the Mayo Clinic College of Medicine and serves as Chief Medical Officer for Screening at Exact Sciences.

    His previous Mayo Clinic leadership roles include Co-Leader of the Cancer Prevention and Control Program, Medical Director for Global Business Solutions, Medical Director for the Office of Health & Well-Being, Physician Lead for Prediction & Prevention in the Center for Innovation, and Research Director for the Healthy Living Program, among others. Dr. Limburg has served on several enterprise-wide committees at Mayo Clinic, including the Management Team and the Clinical Practice Committee.

    Read more

    With respect to his research activities, Dr. Limburg is Principal Investigator for the Cancer Prevention Network, an international, multicenter clinical trial consortium funded by the U. S. National Cancer Institute since 2003. He is a Fellow in the American Gastroenterological Association, an inductee into the honorary American Society for Clinical Investigation, and a member of the Sigma Xi scientific research honor society. His primary research interests include screening innovation, cancer chemoprevention, and molecular epidemiology. To date, Dr. Limburg has published over 140 peer-reviewed articles and 19 book chapters.

    Dr. Limburg earned his BA degree in chemistry from Augustana College (Sioux Falls, SD), MD degree from Mayo Medical School, and MPH degree from the Johns Hopkins School of Hygiene and Public Health. He completed his Internal Medicine residency and Gastroenterology & Hepatology fellowship training at the Mayo Graduate School of Medicine. Dr. Limburg also completed an advanced fellowship in Preventive Oncology at the U. S. National Cancer Institute.

    Dr. Limburg has received numerous awards and honors throughout his career, including a Cancer Prevention Laurel for Dedication to Community Programs from the Cancer Research and Prevention Foundation of America, a Career Development Award from the National Cancer Institute, and the Karis Award from Mayo Clinic. Dr. Limburg was selected to serve as Chair for the 2013 Frontiers in Cancer Prevention Research Program Committee (American Association for Cancer Research) and is widely recognized for his clinical, research, and leadership contributions in the field of cancer prevention.

  • Exact Sciences Laboratories Virtual Lab Tour

    Take this virtual tour for a sneak peek inside Exact Sciences Laboratories in Madison, Wisconsin. Learn how this innovative, customer-focused, mission-driven facility delivers colorectal cancer screening results for patients nationwide with Cologuard®. You will see that no matter how far apart we are, patients are still within reach.
    Take this virtual tour for a sneak peek inside Exact Sciences Laboratories in Madison, Wisconsin. Learn how this innovative, customer-focused, mission-driven facility delivers colorectal cancer screening results for patients nationwide with Cologuard®. You will see that no matter how far apart we are, patients are still within reach.